Bone mineral density changes on androgen deprivation therapy for prostate cancer and response to antiresorptive therapy (Q81455962)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16276350%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Bone mineral density changes on androgen deprivation therapy for prostate cancer and response to antiresorptive therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16276350%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

Yaturu S

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16276350%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

DjeDjos S

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16276350%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Alferos G

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16276350%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Deprisco C

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16276350%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16276350%20AND%20SRC:MED&resulttype=core&format=json

Prostate Cancer and Prostatic Diseases

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16276350%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16276350%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16276350%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

35-38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16276350%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500846

9 January 2020

exact match

0 references

cites work

Controversies surrounding androgen deprivation for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500846

7 January 2021

Leuprolide versus diethylstilbestrol for metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500846

7 January 2021

Zoladex versus orchiectomy in treatment of advanced prostate cancer: a randomized trial. Zoladex Prostate Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500846

7 January 2021

Present and future of osteoporosis therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500846

7 January 2021

Fracture risk following bilateral orchiectomy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500846

7 January 2021

Skeletal fracture associated with androgen suppression induced osteoporosis: the clinical incidence and risk factors for patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500846

7 January 2021

Incidence of bone fracture in patients receiving luteinizing hormone-releasing hormone agonists for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500846

7 January 2021

Alendronate for the Treatment of Osteoporosis in Men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500846

7 January 2021

Prevalence of low femoral bone density in older U.S. women from NHANES III

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500846

7 January 2021

Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500846

7 January 2021

Early postmenopausal diminution of forearm and spinal bone mineral density: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500846

7 January 2021

Progressive osteoporosis during androgen deprivation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500846

7 January 2021

Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500846

7 January 2021

Androgen deprivation therapy for prostate cancer results in significant loss of bone density

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500846

7 January 2021

Bone loss following hypogonadism in men with prostate cancer treated with GnRH analogs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500846

7 January 2021

Exploring the effects of luteinizing hormone-releasing hormone agonist therapy on bone health: implications in the management of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500846

7 January 2021

Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500846

7 January 2021

Bone density and fracture risk in men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500846

7 January 2021

Combination of bone mineral density and upper femur geometry improves the prediction of hip fracture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500846

7 January 2021

The use of bisphosphonates in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500846

7 January 2021

Identifiers

DOI

10.1038/SJ.PCAN.4500846

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16276350%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference